Navigation Links
The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
Date:10/31/2011

NEW YORK, Oct. 31, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion

http://www.reportlinker.com/p0201024/The-Future-of-GPCRs-in-Drug-Discovery-Novel-technologies-leading-companies-and-opportunities-for-target-expansion.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

G-Protein-coupled receptors (GPCRs) constitute the largest family of membrane receptors, and the pharmaceutical industry has targeted them to a greater extent than any other protein class. Despite the high revenues generated by branded drugs that are active at GPCRs, only a small fraction of the GPCR family has thus far been commercially exploited. Consequently, considerable scope exists for broadening the reach of drug discovery efforts to counteract the impending patent expiries of many of the best-selling GPCR-targeted drugs.

This report provides insight into how recent advances in the understanding of GPCR function are opening up new avenues for exploration, where the most promising opportunities lie, and which companies are best placed to advance their GPCR-based proprietary drug discovery technologies. The report begins with outlines of the current commercial status of drugs targeting GPCRs and the scientific basis of their action, offering an understanding of why the large majority of the receptor family has remained unexplo
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Philips Teams up With Integrated Oncology Network, Reinforcing Its Commitment to the Future of Cancer Care
2. CVS Caremark Partners With Hispanic Heritage Foundation to Identify and Inspire Future Latino Health Care Leaders
3. Spot Helps Redefine the Pediatric Office of the Future
4. Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future
5. The Future of European Pharmaceutical Distribution
6. Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding
7. OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference
8. MedInformatix Practice Management and Electronic Medical Records Simplifies Texas Dermatology Practices Current and Future Operations
9. Philips Unveils a Vision for the Future of Cardiac Care at ESC 2011
10. IRS Proposed Regulations on Orphan Drug Exclusion from Drug Tax Stand to Harm Future Development of Treatments for Rare Disease Patients
11. Biopharma Leaders Discuss Pharmas Future at Pharmaceutical Strategic Alliances in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015  AccuTec Blades, Inc. today ... Industrial Blades division.  EPC announced in May 2015 its ... Verona, Virginia and Obregon, ... the sale process. Rick Gagliano ... AccuTec Blades said, "Our new name, AccuTec Blades, reflects ...
(Date:9/1/2015)... , Sept. 1, 2015 Nevro Corp. ... that is providing innovative evidence-based solutions for the treatment ... submitted its preliminary response to the Patent Trial and ... inter partes review (IPR), filed by a unit ... claims in U.S. Patent No. 8,359,102 (the ,102 patent). The ...
(Date:9/1/2015)... YEHUDA, Israel , Sept. 1, 2015 ... ), a leading innovator of less invasive, miniaturized circulatory ... heart failure, announced today that it has entered into ... . ("Valtech").  Valtech is a privately held company that ... valve repair and replacement devices for the treatment of ...
Breaking Medicine Technology:AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 4HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 5HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 6HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 7HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 8HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 9HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 10
... March 30, 2011 Regado Biosciences, a privately held ... control agents, announced that David J. Mazzo, PhD, President ... Company,s 10th Annual Healthcare Conference at the New York ... 6, 2011 at 11:20 a.m. EDT.  The presentation will ...
... Inc. (Nasdaq: ABAX ), a medical products company ... chairman and chief executive officer,  will present at the 10th ... 8:40 a.m. ET. The conference will be held at the ... About Abaxis Abaxis develops, manufactures and markets portable blood ...
Cached Medicine Technology:Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City 2Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City 3
(Date:9/1/2015)... KY (PRWEB) , ... September 01, 2015 , ... ... practice physical therapy company, is pleased to announce their partnership with Apex ... merger allows both groups to continue to provide kind, compassionate, and empathetic care ...
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes in many different ... life changes can lead to very serious, life-altering events. Fortunately nature offers a ... Herbal supplement manufacturer MediHerb has coupled therapeutic doses of Rhodiola and ...
(Date:9/1/2015)... ... 01, 2015 , ... From Aug. 17-21, Calvary Hospital hosted the 18th consecutive ... Camp Compass® has taken place at Kingsborough Community College in Brooklyn in each of ... work for Calvary, and two junior counselors who were campers themselves just a few ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Horizon Blue Cross ... 50 Best Companies for Latinas in the LATINA Style 50 Report that recognizes companies ... , For 2015, Horizon BCBSNJ climbs from number 24 to 21 of ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... cure and prevent different malignancies. Some options for cancer treatment are available ... to which distinctive approach is necessary for effective treatment. Several molecules have ...
Breaking Medicine News(10 mins):Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3
... Reporter , FRIDAY, Nov. 4 (HealthDay News) -- A widely ... a gene that is critical in determining which life-saving treatment ... Genomic Health, results in a number of false-negatives for the ... the Journal of Clinical Oncology . Women ...
... Households Financial strain and competing priorities at ... readmissions of children with asthma from single-parent homes compared ... at the American College of Allergy, Asthma and Immunology ... The study, performed at Cincinnati Children,s Hospital Medical Center, ...
... FRIDAY, Nov. 4 (HealthDay News) -- Online forums help women ... feelings of loss and isolation, according to a new study. ... the women are often driven to the Internet because their ... They noted that half of the women who participate in ...
... -- Over-the-counter "thyroid support" supplements commonly used for weight ... may pose a health threat, a new study warns. ... kinds of thyroid hormones -- triiodothyronine (T3) and thyroxine ... thyroid glands, according to senior investigator Dr. Victor Bernet, ...
... major role in kidney failure, and blocking the action of ... diabetes, according to researchers. "We believe these arginase inhibitors ... down the progression of, or even prevent the development of, ... nephrology, Penn State College of Medicine. In the United States ...
... 4 (HealthDay News) -- Delaying treatment for a herniated disc ... research finds. A study of nearly 1,200 U.S. patients ... herniated lumbar disc symptoms had less pain and disability years ... The patients in the study were older than 18 years ...
Cached Medicine News:Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 3Health News:New interventions, recommendations for controlling allergies & asthma in children 2Health News:New interventions, recommendations for controlling allergies & asthma in children 3Health News:New interventions, recommendations for controlling allergies & asthma in children 4Health News:New interventions, recommendations for controlling allergies & asthma in children 5Health News:Online Forums Can Help Women Cope With Pregnancy Loss 2Health News:Buyer, Beware of Over-the-Counter Thyroid Supplements: Study 2Health News:Research aims to prevent diabetic kidney failure 2Health News:Timing May Be Key to Successful Back Surgery 2
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
Cruciate retaining, posterior stabilized and constrained components....
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
...
Medicine Products: